Published in J Exp Med on September 01, 1989
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Gamma delta T cells differentiate into a functional but nonproliferative state during a normal immune response. Proc Natl Acad Sci U S A (1993) 0.94
Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. J Exp Med (1992) 0.90
Characterization of apoptosis-resistant antigen-specific T cells in vivo. J Exp Med (1996) 0.89
Antigen-presenting cell engineering. The molecular toolbox. Am J Pathol (1996) 0.81
Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J Exp Med (1996) 0.77
Treatment of an autoimmune disease with "classical" T cell veto: a proposal. J Clin Immunol (1999) 0.75
Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med (1987) 5.48
Cellular mechanisms of immunologic tolerance. Annu Rev Immunol (1983) 4.07
Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature (1988) 3.82
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol (1977) 3.13
Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol (1987) 2.85
Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J Immunol (1988) 2.48
The effect of thymus environment on T cell development and tolerance. Cell (1988) 2.45
Quantitative studies on the mixed lymphocyte interaction in rats. V. Tempo and specificity of the proliferative response and the number of reactive cells from immunized donors. J Exp Med (1971) 2.04
Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects. J Immunol Methods (1980) 2.03
Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature (1982) 1.75
Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. II. Potential application to studies of lymphocyte migration and maturation. J Immunol Methods (1980) 1.67
Veto cells. Annu Rev Immunol (1988) 1.56
An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature (1980) 1.40
Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med (1983) 1.31
Anti-idiotypic cytotoxic T cells in rats with graft-versus-host disease. Nature (1984) 1.17
The distribution of 51Cr-labeled syngeneic and allogeneic lymph node cells in the rat. Transplantation (1971) 1.02
Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J Immunol (1984) 1.01
Suppressor cells in transplantation tolerance. II. Identification and probable mode of action of chimeric suppressor T cells. Transplantation (1982) 1.00
Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature (1988) 0.99
Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes. J Immunol (1984) 0.96
Reduction of the in vitro cytotoxic lymphocyte response produced by in vivo exposure to semiallogeneic cells: recruitment or active suppression? J Immunol (1976) 0.94
Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity. J Exp Med (1984) 0.87
Prevention of allograft rejection by immunization with donor blood depleted of Ia-bearing cells. Science (1982) 0.87
Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen. J Immunol (1986) 0.86
Immunoregulation in the rat: characteristics of a suppressor T cell that inhibits antigen-dependent cell proliferation. J Immunol (1985) 0.85
Blood transfusions and kidney transplants: remaining controversies. Transplant Proc (1981) 0.84
Antigen-induced trapping of immunospecific lymphocytes in the spleen. J Immunol (1974) 0.83
Irreversible inactivation of activated cytotoxic T lymphocyte precursor cells by "anti-self" suppressor cells present in murine bone marrow T cell colonies. Eur J Immunol (1984) 0.82
Mutual tolerization of histoincompatible lymphocytes. Eur J Immunol (1987) 0.82
Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance. J Immunol (1983) 0.80
Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells. J Immunol (1987) 0.78
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73
The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med (1977) 4.44
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA (1979) 3.69
Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells. J Immunol (1972) 2.83
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol (1984) 2.56
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2010) 2.22
Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature (1992) 2.22
Subacute, reversible motor neuron disease. Neurology (1991) 2.20
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
Reliability of the thermodilution method in the determination of cardiac output in clinical practice. Am Rev Respir Dis (1982) 2.07
Blunted pressor and intramuscular metabolic responses to voluntary isometric exercise in multiple sclerosis. J Appl Physiol (1985) (2000) 2.04
Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89
Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev (1977) 1.87
What price Kaplan-Meier? Biometrics (1983) 1.73
A quantitative assay for the progenitors of bone marrow-associated lymphocytes. J Exp Med (1972) 1.69
Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell Immunol (1974) 1.68
Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology (1993) 1.61
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology (2004) 1.60
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res (1995) 1.57
Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57
Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med (2010) 1.56
Central basis of muscle fatigue in chronic fatigue syndrome. Neurology (1993) 1.52
Prognosis in AZT myopathy. Neurology (1991) 1.50
Differentiation of rosette-forming cells from myeloid stem cells. J Immunol (1970) 1.49
Homogeneity of antibody-producing cells as analysed by their buoyant density in gradients of Ficoll. Immunology (1970) 1.45
Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia (2007) 1.44
In vivo requirement for a radiation-resistant cells in the immune response to sheep erythrocytes. J Exp Med (1971) 1.41
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol (1996) 1.41
An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature (1980) 1.40
Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol (1981) 1.39
Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc Natl Acad Sci U S A (1981) 1.37
Atomic force microscopy of purple membranes. J Microsc (1988) 1.35
Identification by density separation of antigen-specific surface receptors on the progenitors of antibody-producing cells. Immunology (1971) 1.35
Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med (1980) 1.35
The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep (1984) 1.29
Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol (1993) 1.27
The cubital tunnel syndrome: diagnosis and precise localization. Ann Neurol (1979) 1.25
Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization. J Immunol (1973) 1.25
Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging (1994) 1.24
Particle rosettes in the periaxonal Schwann cell membrane and particle clusters in the axolemma of rat sciatic nerve. Brain Res (1977) 1.23
Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. J Immunol (1994) 1.23
Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21
The natural history of amyotrophic lateral sclerosis. Neurology (1993) 1.21
Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors. J Immunol (1973) 1.20
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci (2001) 1.19
Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2 + M phases after irradiation of a solid tumor in vivo. Cancer Res (1979) 1.19
Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. J Appl Physiol (1985) (1997) 1.16
Chlorine dioxide water disinfection: a prospective epidemiology study. Arch Environ Health (1981) 1.16
A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol (1996) 1.16
Synchronization of mouse L-cells by a velocity sedimentation technique. Biophys J (1970) 1.15
Nerve conduction studies in infants and children. J Child Neurol (1986) 1.14
Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur J Immunol (1993) 1.14
Opposite polarity of filipin-induced deformations in the membrane of condensing vacuoles and zymogen granules. Science (1980) 1.13
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol (1988) 1.13
Mitogenic analysis of murine B-cell heterogeneity. J Exp Med (1978) 1.13
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology (2002) 1.12
Adiposity and mortality in type 1 diabetes. Int J Obes (Lond) (2009) 1.12
Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells. J Cell Physiol (1977) 1.11
Sedimentation analysis of the cells in mice required to initiate an in vivo immune response to sheep erythrocytes. Proc Soc Exp Biol Med (1970) 1.11
A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol (1979) 1.10
Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol (1992) 1.10
Palliative care in amyotrophic lateral sclerosis. Neurol Clin (2001) 1.10
Central core disease: ultrastructure of the sarcoplasmic reticulum and T-tubules. Muscle Nerve (1989) 1.09
Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes. J Immunol (1983) 1.09
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology (1998) 1.09
Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology (1998) 1.09
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
In vitro differentiation of B lymphocytes from pre-B cells. J Immunol (1979) 1.09
Muscle membrane excitation and impulse propagation velocity are reduced during muscle fatigue. Muscle Nerve (1986) 1.08
Acquisition of concomitant oral and genital infection with herpes simplex virus type 2. Sex Transm Dis (1987) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation. J Exp Med (1980) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. V. The cellular basis for the cross-reactivity of TNP-specific clones. J Immunol (1978) 1.07
Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science (1991) 1.06
Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14. Neurology (1995) 1.06
Restriction of specificity in the precursors of bone marrow-associated lymphocytes. J Exp Med (1973) 1.05
Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells. Int Immunol (1992) 1.05
Sporadic distal myopathy with early adult onset. Ann Neurol (1979) 1.05
Volume analysis of human peripheral blood leukocytes. Ser Haematol (1972) 1.05
Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology (2001) 1.05
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Membrane particles on fracture faces of frozen myelin. Proc Natl Acad Sci U S A (1975) 1.04
Marrow environment not required for differentiation of B lymphocytes. Nature (1974) 1.04
Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve (1998) 1.03
Inhibition of the immune response by 7S antibody mechanism and site of action. J Exp Med (1973) 1.03
Conduction block in clinical practice. Muscle Nerve (1991) 1.02
Chancroidal ulcers that are not chancroid. Cause and epidemiology. Arch Dermatol (1984) 1.02
Quantitative studies on the precursors of cytotoxic lymphocytes. II. Specificity of precursors responsive to alloantigens and to concanavalin A. J Immunol (1977) 1.01
Measurement of cytoplasmic fluorescence depolarization of single cells in a flow system. J Histochem Cytochem (1977) 1.00
Do 'lipidic particles' represent intermembrane attachment sites? Nature (1980) 1.00
A modified 51Cr release assay for cytotoxic lymphocytes. J Immunol Methods (1974) 0.99